Oral GLP-1 Pills: Rybelsus, the Wegovy Pill and Foundayo
Oral GLP-1 pills in 2026: how Rybelsus, the Wegovy pill and Foundayo (orforglipron) differ in approval, dosing rules, trial weight loss, cost and switching.
Read the guide →GLP-1 Guides
Plain-English guides to life on a GLP-1 medication, from the first low dose to the day you stop. Each guide is built on the FDA prescribing information and the published trials, and lists its sources at the bottom so you can check every number yourself.
Oral GLP-1 pills in 2026: how Rybelsus, the Wegovy pill and Foundayo (orforglipron) differ in approval, dosing rules, trial weight loss, cost and switching.
Read the guide →Denied a GLP-1 prior authorization? Why Wegovy and Zepbound requests fail, the appeal deadlines for your plan, formulary exceptions, and Medicare rules.
Read the guide →What GLP-1 microdosing means, what the Ozempic, Wegovy and Zepbound labels say about low doses, the one lower-dose trial, and FDA dosing-error warnings.
Read the guide →How much muscle you lose on a GLP-1, who is most at risk, and what SURMOUNT-1 data and the 2025 nutrition advisory say about strength training and protein.
Read the guide →Can you drink alcohol on Ozempic or another GLP-1? What the labels say, where the risks overlap (nausea, dehydration, low blood sugar), and the 2025 trial.
Read the guide →Why weight loss slows on a GLP-1 and what the trials show: STEP 4 numbers after the first months, where dose titration fits, and what to ask your prescriber.
Read the guide →What happens when you stop a GLP-1: how slowly semaglutide and tirzepatide clear, when appetite returns, and how much weight came back in the trials.
Read the guide →Foods to avoid on Wegovy, Zepbound and other GLP-1 medications, what the makers and a 2025 nutrition advisory suggest instead, and daily protein targets.
Read the guide →Your first month on Wegovy or Zepbound: the low starting dose, when side effects tend to appear, and what the scale will and will not do, week by week.
Read the guide →Ozempic vs Mounjaro for weight loss: head-to-head results from SURMOUNT-5 and SURPASS-2, key differences, FDA approval status, and questions to ask.
Read the guide →This content is for educational purposes only and is not medical advice. Talk with a licensed clinician before starting, stopping, or changing any medication. glp1medications.org is not a pharmacy and does not sell or dispense prescription medications.